close
發佈日期：2014年2月6日
The management of Type 2 Diabetes (T2D) is complex and challenging.
Sodium glucose cotransporter 2 (SGLT2) inhibition offers a different mode of action from other oral glucose lowering treatments.
Find out more about SGLT2 inhibition and its potential impact on T2D management.
文章標籤
全站熱搜
留言列表
{{ article.title }}